Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immune system drug may increase availability of liver transplants

30.07.2003


Animal research at The Johns Hopkins University School of Medicine has found that a drug already approved by the FDA for testing in people might one day dramatically expand the number of livers useable for human transplantation.



Studying rats with fatty livers, the researchers discovered that bathing the livers in a human immune system protein called interleukin-6 (IL-6) rescues them from failure when transplanted into other rats. The findings appear in the July issue of Gastroenterology.

Roughly 40 percent of adults in the United States have so-called "fatty" livers, which frequently fail to function at all or fail quickly when transplanted.


"IL-6 really works," says Zhaoli Sun, M.D., Ph.D., a scientist in the department of surgery. Sun cautions that IL-6’s ability to "rescue" fatty livers for transplantation needs to be tested in larger animals, such as pigs, before human studies are undertaken.

"IL-6 is already approved for use in humans, but it has many negative effects when injected," says Sun. "Fortunately, our technique stores the liver in IL-6 before it’s transplanted, rather than giving IL-6 to the organ recipient, so side effects should be minimized."

For his experiments, Sun developed two special rat colonies while an instructor in the laboratory of Andrew Klein, M.D., in collaboration with Anna Mae Diehl, M.D., a professor of gastroenterology whose research has focused on regeneration -- rather than transplantation -- of fatty liver. In humans, fatty livers generally stem from either diet or alcohol consumption, and the two rat models developed fatty livers under equivalent conditions.

After removing a fatty liver from one animal, and before transplanting it into another, Sun bathed the liver in a soup of nutrients that either did or did not include IL-6. Livers soaked in IL-6 had better blood flow and better function and allowed recipients to live, while fatty livers never exposed to IL-6 succumbed quickly to damage and never worked well enough to save their new hosts.

Sun says it’s not known yet how IL-6 protects the fatty livers from damage or how it improves so-called "microcirculation," which helps prevent large chunks of the liver from dying. But while those questions are interesting scientifically, Klein, director of the Johns Hopkins Comprehensive Transplant Center, says clinical trials won’t need to wait for those answers.

"Eventual clinical trials, if approved, would probably begin by looking for reduced damage or improved function in organs we would already use for transplant," says Klein, who notes that that a generally acceptable cutoff is a liver with no more than 30 percent of cells containing big droplets of fat. "Moving toward livers that currently would be borderline would be a gradual process."

Roughly 17,500 people are awaiting liver transplants in the United States, and 5,327 liver transplantations were performed last year across the country, according to statistics kept by the United Network for Organ Sharing. IL-6 has been administered to people as part of early phase clinical trials in adults and children with various cancers, but was limited by its toxicity.

Joanna Downer | EurekAlert!
Further information:
http://www.gastroenterology.com
http://www.hopkinsmedicine.org/transplant/adult/liver/index.html
http://www.unos.org

More articles from Health and Medicine:

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

nachricht Breakthrough in understanding how deadly pneumococcus avoids immune defenses
13.11.2018 | University of Liverpool

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection

13.11.2018 | Life Sciences

Fish recognize their prey by electric colors

13.11.2018 | Life Sciences

Ultrasound Connects

13.11.2018 | Awards Funding

VideoLinks
Science & Research
Overview of more VideoLinks >>>